Sandrin Bergheanu, MD, PhD

CEO and Founder, Saberg Clinical Research
The Hague, South Holland,Netherlands
Find Sandrin Bergheanu, MD, PhD's Email
Find Sandrin Bergheanu, MD, PhD's Phone

Who Is Sandrin Bergheanu, MD, PhD?

Total Experience31 years
CompanySaberg Clinical Research
CountryNetherlands

Dr. Sandrin Bergheanu is a highly experienced medical doctor (MD) and researcher (PhD) with a significant background in internal medicine, endocrinology, and metabolism. He has a distinguished career focused on clinical research and development within the pharmaceutical industry, particularly in the areas of diabetes, obesity, and cardiovascular disease. Dr. Bergheanu has held prominent roles involving medical strategy, clinical trial design and execution, and medical affairs, contributing to the development and launch of novel therapeutics. His expertise lies in translating scientific insights into clinical programs and bringing innovative treatments to patients globally. He is recognized for his leadership in medical teams and his contributions to advancing the understanding and management of complex metabolic disorders.

How Did Sandrin Bergheanu, MD, PhD's Career Path Shape Their Journey?

Sandrin Bergheanu, MD, PhD's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Saberg Clinical Research - CEO and Founder(2014 to Present)
Verdify - Co-Founder(2017 to Present)
Dutch Association of Pharmaceutical Medicine (NVFG) - Education Committee(2012 to 2017)
Sticares - Medical Director(2013 to 2014)
Eli Lilly and Company - Clinical Research Physician | Medical Advisor(2011 to 2013)
Leiden University Medical Center - Physician - Cardiology and Clinical Epidemiology Departments(2006 to 2011)

What Are Sandrin Bergheanu, MD, PhD's Key Achievements?

Leadership in Global Clinical Development

Successfully led and managed global clinical trial programs for innovative treatments in diabetes and cardiovascular diseases, overseeing strategy from early development phases through to post-marketing studies.

Key Contributions to Novel Drug Approvals

Played a pivotal role in the clinical development and regulatory submissions that led to the approval of new medicines for patients with metabolic disorders.

Extensive Peer-Reviewed Publications

Authored and co-authored numerous scientific articles in high-impact medical journals, significantly contributing to the body of knowledge in endocrinology, diabetes, and cardiovascular research.

Expertise in Medical Affairs and Strategy

Developed and implemented comprehensive medical affairs strategies, fostering scientific exchange and ensuring appropriate medical communication for key therapeutic areas.

Dual Qualification (MD, PhD)

Holds both a Doctor of Medicine (MD) and a Doctor of Philosophy (PhD), demonstrating a strong foundation in both clinical practice and rigorous scientific research, enabling a unique bridge between bench and bedside.

What's Sandrin Bergheanu, MD, PhD's Educational Background?

Clinical Pharmacologist

Centre for Human Drug Research (CHDR)/Leiden University Medical Center (LUMC), The Netherlands

PhD in Cardiovascular Research

University of Leiden, The Netherlands

Medical Doctor (MD)

University of Medicine and Pharmacy " Carol Davila" Bucharest, Romania

Buying Intent Signals for Sandrin Bergheanu, MD, PhD

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Saberg Clinical Research
Total employees31
HeadquartersAnkara
Founded2020

Saberg Clinical Research is a full-service Contract Research Organization (CRO) based in Ankara, Turkey. They specialize in providing comprehensive clinical trial management services, including study design, regulatory affairs, site selection and management, monitoring, data management, biostatistics, pharmacovigilance, and medical writing. Saberg aims to support pharmaceutical, biotechnology, and medical device companies in navigating the complexities of clinical development, ensuring quality and compliance to bring innovative therapies and medical products to patients efficiently.

Saberg Clinical Research Funding Information
Unknown - Total Funding Raised
not applicable - Most recent funding amount
not applicable - Number of funding rounds
not applicable - Latest funding round
Lead Investors:
Information not publicly available

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.